PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease Reportsdiabetic nephropathies
MeSH D003928 - diabetic nephropathies
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D007674:Kidney diseases
$
Success rate
D048909:Diabetes complications
$
Success rate
D003928: 
Diabetic nephropathies
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
AbbVieHydrochlorothiazide, Eprosartan Teveten  2001-11-01   
Valsartan, Nebivolol Byvalson 2026-08-29 2016-06-03   
Accord HealthcareOlmesartan medoxomil, Amlodipine besylate Amlodipine Olmesartan Medoxomil  2018-08-30   
Lisinopril Lisinopril  2013-07-30   
Olmesartan medoxomil Olmesartan Medoxomil  2017-04-24   
Hydrochlorothiazide, Olmesartan medoxomil Olmesartan Medoxomil Hydrochlorothiazide  2019-02-07   
Ramipril Ramipril  2014-04-15   
Adhera TherapeuticsPerindopril arginine, Amlodipine besylate Prestalia 2023-04-15 2015-01-21   
Ajanta PharmaOlmesartan medoxomil, Amlodipine besylate Amlodipine Olmesartan Medoxomil  2016-10-28   
Captopril Captopril  2019-12-13   
Irbesartan Irbesartan  2015-12-10   
Alembic PharmaceuticalsValsartan, Amlodipine besylate Amlodipine Besylate Valsartan  2015-04-03   
Olmesartan medoxomil, Amlodipine besylate Amlodipine Olmesartan Medoxomil  2017-07-17   
Candesartan cilexetil Candesartan Cilexetil  2017-06-20   
Irbesartan Irbesartan  2012-10-15   
Irbesartan, Hydrochlorothiazide Irbesartan Hydrochlorothiazide  2012-10-15   
Losartan potassium Losartan Potassium  2010-10-06   
Hydrochlorothiazide, Losartan potassium Losartan Potassium Hydrochlorothiazide  2012-02-17   
Olmesartan medoxomil Olmesartan Medoxomil  2017-04-24   
Hydrochlorothiazide, Olmesartan medoxomil Olmesartan Medoxomil Hydrochlorothiazide  2017-04-24   
Telmisartan Telmisartan  2014-07-07   
Telmisartan, Amlodipine besylate Telmisartan Amlodipine  2016-11-17   
Telmisartan, Hydrochlorothiazide Telmisartan Hydrochlorothiazide  2014-02-25   
Valsartan Valsartan  2015-01-05   
Hydrochlorothiazide, Valsartan Valsartan Hydrochlorothiazide  2013-03-21   
Alkem LaboratoriesOlmesartan medoxomil, Amlodipine besylate Amlodipine Olmesartan Medoxomil  2017-08-14   
Enalapril Enalapril  2022-03-30   
Olmesartan medoxomil Olmesartan Medoxomil  2017-04-24   
Valsartan Valsartan  2019-03-12   
AllerganTelmisartan, Hydrochlorothiazide Actelsar  2013-03-13   
Benazepril, Amlodipine besylate Amlodipine Besylate Benazepril  2010-10-14   
Captopril Captopril  1996-05-23   
Hydrochlorothiazide, Captopril Captopril Hydrochlorothiazide  1997-12-29   
Enalapril Enalapril  2000-08-22   
Fosinopril Fosinopril  2004-10-15   
Irbesartan Irbesartan  2012-10-12   
Irbesartan, Hydrochlorothiazide Irbesartan Hydrochlorothiazide  2012-10-22   
Lisinopril Lisinopril  2002-07-01   
Hydrochlorothiazide, Lisinopril Lisinopril Hydrochlorothiazide  2002-07-01   
Losartan potassium Losartan Potassium  2010-10-06   
Hydrochlorothiazide, Losartan potassium Losartan Potassium Hydrochlorothiazide  2011-01-12   
Ramipril Ramipril  2005-10-24   
Telmisartan Telmisartan Actavis  2010-09-29   
Valsartan Valsartan  2015-01-05   
Hydrochlorothiazide, Valsartan Valsartan Hydrochlorothiazide  2013-03-21   
Almatica PharmaHydrochlorothiazide, Lisinopril Zestoretic  1989-07-20   
Amneal PharmaceuticalsBenazepril, Amlodipine besylate Amlodipine Besylate Benazepril  2018-12-07   
Benazepril Benazepril  2006-02-03   
Enalapril Enalapril  2022-06-29   
Irbesartan Irbesartan  2018-04-17   
Telmisartan Telmisartan  2015-09-08   
Valsartan Valsartan  2016-01-11   
Olmesartan medoxomil Olmesartan Medoxomil  2023-07-11   
Hydrochlorothiazide, Valsartan Valsartan Hydrochlorothiazide  2023-08-11   
ANI PharmaceuticalsCandesartan cilexetil, Hydrochlorothiazide Atacand  1998-06-04   
Benazepril Benazepril  2004-02-11   
Hydrochlorothiazide, Benazepril Benazepril Hydrochlorothiazide  2004-02-11   
Hydrochlorothiazide, Fosinopril Fosinopril Hydrochlorothiazide  2004-12-03   
Perindopril erbumine Perindopril Erbumine  2009-11-10   
1
2
3
4
5
6
...
10
>
Clinical Trials
Historical Success Rate
Phase 1
92%
12/13
Phase 2
57%
27/47
Phase 3
62%
36/58
Approved: 17Overall Success rate: 33%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
AbbVie
1
2
3
4
5
6
7
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use